genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 4.390
0.00 (0.00%)
At close: Jan 23, 2026
genXone Revenue
genXone had revenue of 509.12K PLN in the quarter ending September 30, 2025, with 5.53% growth. This brings the company's revenue in the last twelve months to 2.03M, up 16.29% year-over-year. In the year 2024, genXone had annual revenue of 1.79M, down -25.33%.
Revenue (ttm)
2.03M
Revenue Growth
+16.29%
P/S Ratio
7.16
Revenue / Employee
126.69K
Employees
16
Market Cap
14.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.79M | -606.63K | -25.33% |
| Dec 31, 2023 | 2.39M | -8.19M | -77.38% |
| Dec 31, 2022 | 10.59M | -12.61M | -54.36% |
| Dec 31, 2021 | 23.20M | 2.72M | 13.29% |
| Dec 31, 2020 | 20.47M | 20.27M | 9,907.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Synektik Spólka Akcyjna | 681.60M |
| Voxel | 568.83M |
| Zortrax | 9.06M |
| InventionMed | 2.28M |
| Nestmedic | 1.05M |
| Adiuvo Investments | 1.00M |